Global Head Lice Infestation Drug Market Insights, Forecast to 2025

Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person.
The Global Main Head Lice Infestation Drug Manufacturers are Bayer, Omega Pharma, Thornton and Ross, Prestige Brands and other manufacturers. Bayer is one of the largest manufacturers in the global Head Lice Infestation Drug market with 11.35% market share in 2015, followed by Omega Pharma with 7.98% market share.
The Head Lice Infestation Drug sales regions are mainly North America and Europe. North America is the largest region to consumption Head Lice Infestation Drug, whose consumption occupied about 31.40% in 2015, followed by Europe with 29.01% consumption share.
After a long investigation and research, we think people are very concerned about the Head Lice Infestation Drug content in the daily commodities. We recommend that some manufacturers would add Head Lice Infestation Drug to satisfy the market demanding for all household members and other close to head lice contacts should be checked.
The global Head Lice Infestation Drug market is valued at 340 million US$ in 2018 and will reach 450 million US$ by the end of 2025, growing at a CAGR of 3.3% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Head Lice Infestation Drug market based on company, product type, end user and key regions.

This report studies the global market size of Head Lice Infestation Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Head Lice Infestation Drug in these regions.
This research report categorizes the global Head Lice Infestation Drug market by top players/brands, region, type and end user. This report also studies the global Head Lice Infestation Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO

Market size by Product
Lotion
Creams
Shampoo
Other
Market size by End User
Children
Adult

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Head Lice Infestation Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Head Lice Infestation Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Head Lice Infestation Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Head Lice Infestation Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Head Lice Infestation Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Head Lice Infestation Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions